Periodic Reporting for period 1 - NANEMIAR (Nanomedicine Approach to Normalize Erythrocyte Maturation in Congenital Anemia by messenger RNA)

The NANEMIAR project emerges amidst a transformative era in therapeutics, where conventional drug strategies have historically relied on small molecules. However, a paradigm shift is underway, with antibody-based drugs and genetic-based therapies for rare diseases gaining...